The global elastography imaging market size was estimated at USD 2.28 billion in 2024 and is projected to reach USD 3.47 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.32% during the forecast period from 2025 to 2030. The market’s growth is primarily driven by the increasing prevalence of chronic liver diseases and breast cancer, along with the rising demand for advanced diagnostic imaging technologies. Elastography imaging plays a crucial role in improving diagnostic accuracy, particularly in early disease detection, by allowing clinicians to evaluate tissue stiffness and elasticity without the need for invasive biopsies. Moreover, the growing preference for minimally or non-invasive surgical procedures is further expected to boost market adoption, as patients and healthcare providers continue to prioritize safer, faster, and more comfortable diagnostic options over conventional methods.

The elastography technique is gaining substantial traction and widespread acceptance among both patients and healthcare professionals due to its non-invasive nature and high precision in assessing tissue mechanical properties. By providing real-time visualization and quantitative analysis of tissue elasticity, elastography enables more accurate differentiation between benign and malignant lesions. Advanced elastography systems are now equipped to deliver both qualitative and quantitative diagnostic information, helping physicians make better-informed clinical decisions. In addition, the increasing healthcare infrastructure development in emerging economies and the growing need for sophisticated diagnostic technologies are encouraging hospitals and imaging centers in developing nations to adopt elastography over traditional ultrasound methods. This transition is anticipated to significantly enhance diagnostic efficiency and drive global market expansion in the coming years.

Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) into elastography systems is transforming the diagnostic landscape. These technologies enhance image quality, automate interpretation, and improve the consistency and reliability of results, making elastography more efficient and widely applicable across clinical environments. This fusion of imaging innovation and AI-driven analytics is expected to open new avenues for precision diagnostics in oncology, hepatology, and musculoskeletal imaging.

Key Market Trends & Insights:

  • Regional Insights: The North American elastography imaging market held the largest share of 33.2% in 2024, supported by advanced healthcare infrastructure, high adoption of diagnostic imaging technologies, and the presence of major industry players. Meanwhile, the Asia Pacific market is projected to grow at the fastest rate during the forecast period, fueled by the rising incidence of liver and breast diseases, expanding healthcare expenditure, and increasing awareness about the benefits of non-invasive diagnostic tools. Countries such as China, India, and Japan are witnessing accelerated adoption of elastography systems as part of their healthcare modernization efforts.
  • By Modality: Based on modality, the ultrasound segment dominated the market, holding a share of over 69.40% in 2024. This dominance is attributed to the cost-effectiveness, ease of operation, and portability of ultrasound-based elastography systems, which make them suitable for both hospital and outpatient settings. Conversely, the MRI-based elastography segment is anticipated to exhibit lucrative growth during the forecast period, driven by its superior imaging precision, advanced soft-tissue characterization capabilities, and increasing use in specialized diagnostic applications such as brain and cardiac imaging.
  • By Application: In terms of application, the general imaging segment accounted for the largest revenue share of 32.5% in 2024, supported by its broad utility in assessing various organs and tissues, including the liver, kidneys, and thyroid. The breast imaging segment, on the other hand, is projected to register the fastest CAGR of 8.40% over the forecast period. The increasing global incidence of breast cancer, coupled with growing awareness of early diagnosis, is driving the adoption of elastography as a complementary tool to mammography and conventional ultrasound in detecting malignant lesions.
  • By End Use: Based on end-use segmentation, the hospital segment dominated the global elastography imaging market in 2024, capturing a share of 39.81%. Hospitals remain primary users of elastography systems due to their access to advanced imaging infrastructure, large patient bases, and multidisciplinary diagnostic teams. The imaging centers segment, however, is anticipated to exhibit lucrative growth at a CAGR of 7.71% over the forecast period, as the demand for outpatient diagnostic services and specialized imaging clinics continues to rise. The growing preference for affordable, accessible diagnostic options outside traditional hospital settings is expected to propel this segment’s expansion.

Order a free sample PDF of the Elastography Imaging Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

  • 2024 Market Size: USD 2.28 Billion
  • 2030 Projected Market Size: USD 3.47 Billion
  • CAGR (2025-2030): 7.32%
  • North America: Largest market in 2024
  • Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

Leading players in the elastography imaging industry, including Canon Medical Systems Corporation, GE Healthcare, and Koninklijke Philips N.V., are heavily investing in research and development (R&D) to introduce technologically advanced and more efficient imaging systems. These companies are also focusing on strategic collaborations, partnerships, and mergers to enhance product portfolios, expand geographical reach, and strengthen market presence. By integrating elastography with complementary imaging modalities such as MRI and CT, these manufacturers aim to offer comprehensive diagnostic solutions tailored to varied clinical needs.

Meanwhile, emerging players such as Esaote SpA and Samsung Medison Co., Ltd. are emphasizing product innovation and differentiation to establish a competitive foothold in the market. These companies are developing cost-effective elastography solutions designed to meet the needs of small and mid-sized healthcare facilities. Additionally, they are expanding their global distribution networks through partnerships with regional distributors and healthcare providers to increase accessibility in both developed and developing regions. Many of these players are adopting value-driven strategies, including affordable pricing models and service-based offerings, to attract a larger customer base and promote the wider adoption of elastography imaging technologies across diverse healthcare ecosystems.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

In conclusion, the global elastography imaging market is on a strong growth trajectory, driven by technological advancements, the rising burden of chronic diseases, and the growing shift toward non-invasive diagnostic methods. As awareness about early disease detection continues to rise and healthcare systems increasingly prioritize patient safety and comfort, elastography is emerging as a key diagnostic modality across multiple medical disciplines. With continuous innovation, integration of AI, and expanding applications, the market is poised to witness substantial growth and wider clinical acceptance worldwide between 2025 and 2030.